DIRECTOR AGREEMENTDirector Agreement • August 14th, 2017 • Immudyne, Inc. • Medicinal chemicals & botanical products • Texas
Contract Type FiledAugust 14th, 2017 Company Industry JurisdictionThis DIRECTOR AGREEMENT (“Agreement”) is dated as of July 24, 2017, between IMMUDYNE, INC., a Delaware corporation (the “Company”), and Justin Schreiber (“Director”). The Company and the Director are hereinafter sometimes referred to collectively as the “Parties” and individually as a “Party.”
EMPLOYMENT AGREEMENTEmployment Agreement • August 14th, 2017 • Immudyne, Inc. • Medicinal chemicals & botanical products • Texas
Contract Type FiledAugust 14th, 2017 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of July 1, 2017 (the “New Effective Date”), by and between IMMUDYNE, INC., a Delaware corporation (the “Company”), and Mark McLaughlin, an individual and resident of the State of New York (the “Executive”).
SECOND AMENDMENT TO SERVICES AGREEMENTServices Agreement • August 14th, 2017 • Immudyne, Inc. • Medicinal chemicals & botanical products
Contract Type FiledAugust 14th, 2017 Company IndustryTHIS AGREEMENT (this “Agreement”) is made as of July 1, 2017 (the “Effective Date”) by and between JLS Ventures, LLC, a Puerto Rico limited liability company (“JLS”) and ImmuDyne, Inc., a corporation with a place of business 50 Spring Meadow Road, Mt. Kisco, NY 10549 (“Company”).